UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000025513
Receipt number R000029325
Scientific Title Effectiveness of a mobile menstrual management app on health care and work productivity for working women
Date of disclosure of the study information 2017/01/04
Last modified on 2018/11/20 15:00:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effectiveness of a mobile menstrual management app on health care and work productivity for working women

Acronym

Effectiveness of a mobile menstrual management app for working women

Scientific Title

Effectiveness of a mobile menstrual management app on health care and work productivity for working women

Scientific Title:Acronym

Effectiveness of a mobile menstrual management app for working women

Region

Japan


Condition

Condition

Not applicable

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the effectiveness of a mobile menstrual management app on preventing diseases and work productivity impairment.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Work productivity (WPAI score), incidence of diseases (related to menstrual period and depression), depression (PHQ-9 score) at baseline, 1, 2, and 3 months from start.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

Use of a mobile menstrual management app (for 3 months)

Interventions/Control_2

No intervention

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

45 years-old >=

Gender

Female

Key inclusion criteria

1) Aged between 20 and 45.
2) Selected as full-time worker, and one of the following answers: office worker, company executive, public servant, self-employment, professional, or temporary employee/contract worker.
3) Answered as non-pregnant.
4) Had never downloaded the app used in the trial nor applied for membership of the app.
5) Smartphone user.

Key exclusion criteria

1) Aged less than 20 or more than 46.
2) Selected as one of the following answers: part-time worker, student, housewife, or others.
3) Not full-time worker.
4) Answered as pregnant.
5) Had downloaded the app used in the trial or applied for membership of the app.
6) Not smartphone user.

Target sample size

1500


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hidenobu Kanaoka

Organization

docomo Healthcare, Inc.

Division name

Women's and Children's Healthcare Department

Zip code


Address

Ebisu Business Tower 4F 1-19-19, Ebisu, Shibuya-ku, Tokyo, Japan

TEL

03-6721-7529

Email

hidenobu.kanaoka.hk@d-healthcare.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Tomomi Takeshima

Organization

Milliman. Inc

Division name

Japan Healthcare Practice and Data Analysis

Zip code


Address

ACN Hanzomon Building 12F, 2-2-22 Kojimachi, Chiyoda-ku, Tokyo, Japan

TEL

03-5211-7031

Homepage URL


Email

tomomi.takeshima@milliman.com


Sponsor or person

Institute

docomo Healthcare, Inc.

Institute

Department

Personal name



Funding Source

Organization

docomo Healthcare, Inc.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Anterio Inc., Intage Inc.

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 01 Month 04 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

https://www.tandfonline.com/doi/full/10.1080/13696998.2018.1515082

Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 12 Month 12 Day

Date of IRB


Anticipated trial start date

2017 Year 01 Month 06 Day

Last follow-up date


Date of closure to data entry

2017 Year 05 Month 31 Day

Date trial data considered complete

2017 Year 06 Month 30 Day

Date analysis concluded

2017 Year 09 Month 30 Day


Other

Other related information



Management information

Registered date

2017 Year 01 Month 04 Day

Last modified on

2018 Year 11 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029325


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name